Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Holding(s) in Company

13 Feb 2019 16:24

RNS Number : 9398P
Civitas Social Housing PLC
13 February 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Civitas Social Housing Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

FIL LIMITED

City and country of registered office (if applicable)

Pembroke, Bermuda

4. Full name of shareholder(s) (if different from 3.) See Section 9

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

11 February 2019

6. Date on which issuer notified (DD/MM/YYYY):

13 February 2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

Below 5%

Below 5%

Below 5%

622,461,380

Position of previous notification (if

applicable)

5.40%

n/a

5.40%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BD8HBD32

Below 5%

Below 5%

SUBTOTAL 8. A

Below 5%

Below 5%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

FIL Limited

FIL Holdings (Luxembourg) SA

FIL Investment Management (Luxembourg) S.A.

FIL Limited

FIL Holdings (UK) Limited

FIL Investments International

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional information

 

Place of completion

Dublin

Date of completion

13/02/2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUOUNRKAAUAAR
Date   Source Headline
13th Feb 20194:24 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSNet Asset Values, Investment and Market Update
25th Jan 20194:39 pmRNSBespoke Supportive Tenancies: Grading Under Review
18th Jan 20193:01 pmRNSDirector/PDMR Shareholding
18th Jan 20192:59 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
14th Jan 20193:51 pmRNSHolding(s) in Company
14th Jan 20193:48 pmRNSHolding(s) in Company
2nd Jan 20194:16 pmRNSTotal Voting Rights
24th Dec 201811:45 amRNSHolding(s) in Company
21st Dec 20187:00 amRNSAcquisition
20th Dec 20185:45 pmRNSCivitas Social Housing
20th Dec 20185:29 pmRNSDirector/PDMR Shareholding
20th Dec 20181:28 pmRNSCONVERSION OF C SHARES
5th Dec 20187:00 amRNSUpdate on Westmoreland and the Company's Portfolio
5th Dec 20187:00 amRNSAcquisition
30th Nov 201810:07 amRNSAdviser's Update
29th Nov 20187:00 amRNSDividend Declaration
29th Nov 20187:00 amRNSHalf-year Report
15th Nov 20187:00 amRNSConversion of C Shares
9th Nov 20187:00 amRNSFTSE 250 Index Inclusion
8th Nov 20186:12 pmRNSWoodford Patient Capital Trust
2nd Nov 20187:00 amRNSAcquisition
1st Nov 20187:00 amRNSNet Asset Values, Investment and Market Update
31st Oct 20187:00 amRNSAcquisition
22nd Oct 20187:00 amRNSAcquisition
4th Oct 20187:00 amRNSAcquisition
20th Sep 20185:11 pmRNSHolding(s) in Company
7th Sep 201810:00 amRNSEPRA Index Inclusion
7th Sep 20187:00 amRNSAcquisition
29th Aug 20189:57 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
29th Aug 20189:35 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
28th Aug 20187:00 amRNSAcquisition
24th Aug 201812:57 pmEQSHardman & Co Research: Civitas Social Housing (CSH): Housing security
22nd Aug 201811:22 amRNS£37.6m acquisition of regulated social housing
9th Aug 201811:48 amRNSHolding(s) in Company
6th Aug 20187:00 amRNSAcquisition
3rd Aug 20187:00 amRNSNet Asset Values, Investment and Market Update
2nd Aug 20186:05 pmRNSResult of AGM
3rd Jul 20187:00 amRNSNotice of AGM
14th Jun 20188:23 amRNS£5.4 million acquisition
13th Jun 201810:04 amRNSInitiation research from QuotedData
12th Jun 20187:00 amRNSAnnual Results
12th Jun 20187:00 amRNSPublication of Independent Social Impact Report
12th Jun 20187:00 amRNS£20m increase in 3-Year Revolving Loan Facility
11th Jun 20187:00 amRNS£500 million Invested into Social Housing
11th Jun 20187:00 amRNSAcquisition
1st Jun 20187:00 amRNSAcquisition
30th May 20189:13 amRNSNet Asset Values, Investment and Market Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.